Guo, Ruifeng
Wang, Xiao
Guo, Qian
Yan, Yan
Gong, Wei
Zheng, Wen
Zhao, Guanqi
Wang, Hui
Xu, Lei
Nie, Shaoping
Funding for this research was provided by:
Beijing Nova Program (Z201100006820087, Z211100002121165)
National Key R&D Program of China (2020YFC2004800)
National Natural Science Foundation of China (81870322, 81900454, 81970292, 82100260)
Natural Science Foundation of Beijing Municipality (7191002, 7222046)
Article History
Received: 20 May 2022
Revised: 4 October 2022
Accepted: 23 December 2022
First Online: 26 January 2023
Declarations
:
: The scientific guarantor of this publication is Professor Shaoping Nie.E-mail: spnie@ccmu.edu.cn.
: Dr. Shaoping Nie declares relationships with the following companies: Boston Scientific, Abbott, Jiangsu Hengrui Pharmaceuticals, China Resources Sanjiu Medical & Pharmaceuticals, East China Pharmaceuticals. The rest of the authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: One of the authors (Dr Wen Zheng) has significant statistical expertise.
: Written informed consent was obtained from all patients in this study.
: Institutional Review Board approval was obtained. This study was approved by the institutional review board of Beijing Anzhen Hospital, Capital Medical University.
: • prospective• observational• performed at one institution